Relay Therapeutics Company

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.
Technology: Biotechnology, Health Care, Therapeutics
Industry: End-to-end Drug Development
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2016-01-01
Employees Number: 101-250
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 12
Total Funding: 520000000
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-12-20
Last Funding Type: Series C

Visit Website
Register and Claim Ownership